Terbutaline Turbuhaler

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Asthma

Phase 3

A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®

CompletedNCT00244608

AstraZenecaAsthma

Start: 2005-05-31End: 2007-03-31Target: 100Updated: 2011-01-24

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

CompletedNCT00837967

AstraZenecaAsthma

Start: 2009-01-31End: 2009-07-31Updated: 2012-08-29

Study to Investigate the Efficacy of Symbicort® SMART.

CompletedNCT00839800

AstraZenecaAsthma

Start: 2009-02-28End: 2011-02-28Updated: 2012-11-30

Related Papers

Detecting asthma exacerbations using daily home monitoring and machine learning.

2020-08-1418 citations

Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.

2013-02-0130 citations

Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.

2012-01-012 citations